Once engaged, activated T-cells release cytotoxic molecules like perforin and granzymes, along with pro-inflammatory cytokines (e.g., tumor necrosis factor alpha (TNFα), interleukin (IL)-6), at the tumor interface, leading to cancer cell lysis [6,8]. Here, PRF1 is linked to neoplasm.